What’s the future of aortic valve replacement?

What’s the future of aortic valve replacement?

Our panel of experts Matt BradyRos Lancaster, Professor Geoff Moggridge and Lin Bowker-Lonnecker share their insights from both an academic and commercial perspective, on the impact of a range of current and future innovation pressures on the exciting and growing medical device space of TAVR (Transcatheter Aortic Valve Replacement).

Matt Brady

Partner & head of medical therapy

Ros Lancaster

Insights for innovation consultant

Geoff Moggridge

Professor, University of Cambridge

Lin Bowker-Lonnecker

Medical Device Engineer, Arete Medical Tecnologies

Please complete the 4 fields displayed below to watch the panel discussion in full.

* indicates required

Please select all the ways you would like to hear from :

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices here.